Everything about these phases was cut short and I wouldn't be surprised if the P1 dosing and safety was cut short with early results; and with the data coming in, they adjusted the dosing on the sly and never reported to obviously hide their fuck up by cutting corners (again).

My wife and I with a combined 13.5 years in clinical trials could not figure out how the fuck they (1)got that data so fast NOR could we fathom how (2)they were able to maintain QA on such a large scale OR (3)ramp up production so fast AND maintain QA along the way.

There is definitely some shit going on and it the smell is bad.. really bad.

----------

Irregular Warfare is now in play